FibroGen
FGEN
FGEN
225 hedge funds and large institutions have $3.15B invested in FibroGen in 2019 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 75 increasing their positions, 72 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.03% more ownership
Funds ownership: 2.67% → 2.71% (+0.03%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
75% less call options, than puts
Call options by funds: $43.5M | Put options by funds: $175M
Holders
225
Holding in Top 10
4
Calls
$43.5M
Puts
$175M
Top Buyers
| 1 | +$34.2M | |
| 2 | +$25.7M | |
| 3 | +$18.7M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$17.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$14.7M |
Top Sellers
| 1 | -$73.7M | |
| 2 | -$23.1M | |
| 3 | -$7.58M | |
| 4 |
BlackRock
New York
|
-$7.41M |
| 5 |
Citigroup
New York
|
-$7.33M |